🔍 Observations
Topline
- Revenue surged 46% YoY (₹10,981M → ₹16,032M), with Q4FY26 alone at ₹4,799M — 40% above Q4FY25 (₹3,428M), signalling sustained demand acceleration, not a one-quarter aberration.
- Sequential Q3→Q4 growth of 15% (₹4,175M → ₹4,799M) confirms momentum is building within the year, not plateauing.
- Revenue scale has nearly 1.5x’d in a single year — exceptional for an EMS player and indicative of wallet-share gains or new programme ramp-ups with existing clients.
Bottomline
- Net profit more than doubled YoY: ₹634M → ₹1,129M (+78%), with EPS rising from ₹9.62 to ₹16.95 (basic) — a significant re-rating trigger.
- Q4FY26 PAT of ₹412M is 69% above Q4FY25 (₹243M), and 26% above Q3FY26 (₹326M) — sequential as well as annual acceleration intact.
- Effective tax rate held steady at ~26.5% (₹407M on ₹1,536M PBT), so profit growth is operationally driven, not tax-benefit inflated.
Margins
- EBITDA (PBT + Finance costs + D&A): FY26 = ₹1,536M + ₹150M + ₹336M = ₹2,022M on revenue of ₹16,032M → EBITDA margin ~12.6% vs FY25: (₹867M + ₹167M + ₹286M) / ₹10,981M = ₹1,320M / ₹10,981M = ~12.0%. Modest but meaningful 60bps expansion.
- Net profit margin improved from 5.8% (₹634M / ₹10,981M) to 7.0% (₹1,129M / ₹16,032M) — 120bps expansion at PAT level, better than EBITDA expansion, reflecting lower finance costs as a share of revenue.
- Employee costs rose from 18.1% of revenue (FY25) to 17.5% (FY26) — operational leverage visible in the largest cost head after raw materials.
Growth Trajectory
- Revenue CAGR implied over 1 year: 46%. Raw material consumption grew from ₹7,188M to ₹11,061M (+54%), slightly outpacing revenue — worth monitoring for input cost pass-through efficiency.
- PAT growth (78%) decisively outpacing revenue growth (46%) = positive operating leverage at work.
- Q4FY26 run-rate of ~₹4,800M implies annualised revenue of ~₹19,200M — suggesting FY27 organic growth could sustain 15–20%+ even without fresh programme additions.